Combination treatment of a PAPD5/7 inhibitor with an antisense oligonucleotide bepirovirsen with concurrent dosing shows additive HBsAg decreases in the AAV-HBV mouse model
Authors:
- Jared DelahayeJDJared Delahaye
- Edward LongELEdward Long
- Chi LauCLChi Lau
- Jacob ParsonsJPJacob Parsons
- Bo WenBWBo Wen
- Zhiyi CuiZCZhiyi Cui
- Melanie PaffMPMelanie Paff
- Shihyun YouSYShihyun You
- Martin LeiversMLMartin Leivers
- 4 July 2022
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 77, S880